Home » 2017 » January
Lung cancer drug Oncoprex phase II trial : Genprex reports positive interim data results

Lung cancer drug Oncoprex phase II trial : Genprex reports positive interim data results

Texas based bio-pharma Genprex has announced positive interim data from an ongoing phase II clinical trial of its lung cancer drug candidate Oncoprex. Titled as NCT01455389, the phase II trial of Oncoprex is evaluating the investigational immunogene therapy drug candidate in combination with erlotinib (Tarceva), a tyrosine kinase inhibitor (TKI) in patients with late stage […]